Literature DB >> 2960338

Oblique views in magnetic resonance imaging of the heart by combined axial rotations.

A C Van Rossum1, F C Visser, M J Van Eenige, J Valk, J P Roos.   

Abstract

Magnetic resonance imaging of the heart, and more specifically of the left ventricle (LV), is optimized by using oblique imaging planes adapted to the long and short axes of the LV, comparable to other imaging modalities in cardiology. We report a procedure to perform two chamber views, four chamber views and true short axis views by combinations of electronic axial rotations. The technique of selecting appropriate gradient angles is explained. Thus, there is no requirement for altering patient position in the imager, while individual anatomic variations are taken into account.

Entities:  

Mesh:

Year:  1987        PMID: 2960338

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  3 in total

1.  Aorto-mitral valvular evaluation with MRI using the left parasternal long axis (angled-vertical long axis) plane.

Authors:  Thomas G Vrachliotis; Kostaki G Bis; Nazifa Sajady
Journal:  Int J Cardiovasc Imaging       Date:  2002-02       Impact factor: 2.357

2.  Accuracy of short-axis cardiac MRI automatically derived from scout acquisitions in free-breathing and breath-holding modes.

Authors:  M G Danilouchkine; J J M Westenberg; B P F Lelieveldt; J H C Reiber
Journal:  MAGMA       Date:  2005-01-28       Impact factor: 2.310

3.  Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery.

Authors:  Samuele Nanni; Luigi Lovato; Gabriele Ghetti; Fabio Vagnarelli; GianGaspare Mineo; Rossella Fattori; Francesco Saia; Antonio Marzocchi; Cinzia Marrozzini; Maurizio Zompatori; Letizia Bacchi Reggiani; Franco Semprini; Giovanni Melandri; Elena Biagini; Anna Corsini; Giulia Norscini; Claudio Rapezzi
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-28       Impact factor: 2.357

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.